在外科手术期间使用类似葡萄糖-1受体激动剂和术后结果的关联
相关实验视频
Updated: Jun 4, 2025

07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
23.5K
Seth Z Aschen1, Ashley Zhang2, Gillian M O'Connell2
1Department of Surgery, Weill Cornell Medicine, New York, NY.
Annals of surgery
|December 20, 2024
概括
服用葡萄糖类-1受体激动剂 (GLP-1 RA) 药物的糖尿病患者经历的手术并发症较少. 在外科手术期间使用GLP-1 RA与减少再入院,伤口脱和血液瘤有关.
科学领域:
- 内分泌学和新陈代谢学
- 手术结果研究研究.
- 药理干预药理干预
背景情况:
- 越来越多地使用类似葡萄糖-1受体激动剂 (GLP-1 RAs),需要了解它们对手术结果的影响.
- 糖尿病管理对于优化手术患者护理至关重要.
研究的目的:
- 评估糖尿病患者的外科并发症和再入院率,包括有或没有术后GLP-1RA处方.
- 评估GLP-1RA使用与特定的术后不良事件之间的关联.
主要方法:
- 对接受手术的糖尿病患者进行了回顾性观察性队列分析.
- 倾向性得分匹配,以比较具有和没有活性GLP-1RA处方的患者之间的结果.
- 分析30天的再入院和180天的手术部位并发症 (衰变,感染,血瘤,出血).
主要成果:
- 积极的GLP-1RA处方与30天再入院风险显著降低有关 (RR:0.883).
- 在GLP-1 RA组中观察到手术后伤口脱光 (RR:0.711) 和血瘤 (RR:0.440) 的风险降低.
- 两组之间没有发现术后感染或出血率的显著差异.
结论:
- 糖尿病患者在外科手术期间使用GLP-1RA与风险调整后再入院的降低,伤口脱光和血液瘤有关.
- GLP-1 RA治疗没有显著影响手术部位感染或出血率.
- 需要进一步的研究来证实GLP-1RA使用与改善手术结果之间的因果关系.
相关概念视频
Glucagon-like Receptor Agonists
297
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
297
Hypoglycemia and Glucagon
150
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150
Oral Hypoglycemic Agents: Glinides
136
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
136
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
155
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
155
Dipeptidyl Peptidase 4 Inhibitors
167
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
167
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
48
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
48

